| SC 13G | 2024-03-25 | INCYTE CORP | Merus N.V. | 4,004,544 | 6.9% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | INCYTE CORP | 22,519,381 | 10.0% | EDGAR |
| SC 13G/A | 2024-02-13 | DODGE & COX | INCYTE CORP | 16,090,421 | 7.2% | EDGAR |
| SC 13G/A | 2024-01-24 | BlackRock Inc. | INCYTE CORP | 24,297,249 | 10.8% | EDGAR |
| SC 13G/A | 2023-12-08 | VANGUARD GROUP INC | INCYTE CORP | 22,466,463 | 10.0% | EDGAR |
| SC 13D/A | 2023-08-14 | INCYTE CORP | Merus N.V. | 4,004,544 | 6.9% | EDGAR |
| SC 13G/A | 2023-06-08 | BlackRock Inc. | INCYTE CORP | 23,468,952 | 10.5% | EDGAR |
| SC 13D/A | 2023-03-15 | BAKER BROS. ADVISORS LP | INCYTE CORP | 36,280,967 | 16.3% | EDGAR |
| SC 13G/A | 2023-02-14 | DODGE & COX | INCYTE CORP | 19,362,935 | 8.7% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | INCYTE CORP | 21,533,818 | 9.7% | EDGAR |
| SC 13G/A | 2023-02-08 | INCYTE CORP | Calithera Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-01-25 | BlackRock Inc. | INCYTE CORP | 19,836,617 | 8.9% | EDGAR |
| SC 13D/A | 2022-03-10 | BAKER BROS. ADVISORS LP | INCYTE CORP | 36,269,307 | 16.4% | EDGAR |
| SC 13D/A | 2022-02-14 | BAKER BROS. ADVISORS LP | INCYTE CORP | 34,851,571 | 15.7% | EDGAR |
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | INCYTE CORP | 7,271,688 | 3.2% | EDGAR |
| SC 13G | 2022-02-14 | DODGE & COX | INCYTE CORP | 16,657,586 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-11 | INCYTE CORP | AGENUS INC | 12,070,195 | 4.7% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | INCYTE CORP | 20,944,759 | 9.5% | EDGAR |
| SC 13G/A | 2022-02-04 | WELLINGTON MANAGEMENT GROUP LLP | INCYTE CORP | 9,008,491 | 4.1% | EDGAR |
| SC 13G/A | 2022-02-01 | BlackRock Inc. | INCYTE CORP | 18,336,658 | 8.3% | EDGAR |